surmount-1 trial tirzepatide obesity without diabetes weight loss Demonstrates 94% Reduction, 22% in SURMOUNT -1 Study Tirzepatide Was Associated with Improved

Insulin: A Comparative Analysis in Type 2 Diabetes Treatment

Cardiovascular and Vascular Benefits: GLP-1s can reduce the risk of major cardiovascular events, such as nonfatal heart attacks, nonfatal strokes, and cardiovascular deatheven in patients without diabetes

Weight loss often improves sleep symptoms

Berberine acts on AMP-activated protein kinase and can complement the incretin pathway without significant interaction risk

GHK-Cu, by contrast, has only preclinical (laboratory and animal) evidence and has not been validated in large-scale human trials

Other major contributors to chronic inflammation include: Blood Sugar Imbalances Dehydration Electromagnetic Radiation (Phones, WiFi, Electronics, etc.) Chronic Emotional Stress Sedentary Lifestyle To give your body the best chances of overcoming an autoimmune condition, you must address as many of these areas as possible